HUMANA INC. (HUM) FY2024 Annual Statement of Cash Flows

Income StatementCash FlowBalance Sheet

Statement of Cash Flows

2024-01-01 to 2024-12-31

Swipe to see the full flow
HUMANA INC. cash flow reconciliation, Jan 1, 2024 through Dec 31, 2024One connected Sankey reconciles operating, investing and financing net cash flows through a shared cash pool, from beginning cash to ending cash. Ribbons flow left to right on one dollar scale. Activity totals are dark gray; beginning and ending cash are blue. Cash basis for beginning and ending balances and net cash change: Cash, cash equivalents, and restricted cash. Intermediate calculation bars are lighter gray. Net income is green for profit and red for loss. Identified asset purchases, sales and maturities are blue in either cash direction. Orange marks positive customer-advance and deferred-revenue changes that add to operating cash in the reconciliation. These are net changes, not gross customer receipts. Negative changes are neutral reconciliation adjustments; they do not by themselves identify cash payments. Purple identifies capital transactions such as borrowing, repayments, share issuance and dividends. Free cash flow is a separate comparison, not an added cash flow. Read chart description and values below for full signed amounts, including zero items.Net income → Net cash from operating activities: $1,214,000,000.00Other assets → Operating adjustments reconciliation: $1,003,000,000.00Depreciation → Operating adjustments reconciliation: $908,000,000.00Impairment of property and equipment → Operating adjustments reconciliation: $237,000,000.00Stock-based compensation → Operating adjustments reconciliation: $207,000,000.00Impairment of indefinite-lived intangible assets → Operating adjustments reconciliation: $200,000,000.00Benefits payable → Operating adjustments reconciliation: $199,000,000.00Other, net → Operating adjustments reconciliation: $108,000,000.00Equity in net losses → Operating adjustments reconciliation: $94,000,000.00Amortization → Operating adjustments reconciliation: $60,000,000.00Operating adjustments reconciliation → Net cash from operating activities: $1,752,000,000.00Operating adjustments reconciliation → Receivables: $669,000,000.00Operating adjustments reconciliation → Other liabilities: $373,000,000.00Operating adjustments reconciliation → Deferred income taxes: $192,000,000.00Operating adjustments reconciliation → (Gain) loss on investment securities, net: $24,000,000.00Operating adjustments reconciliation → Unearned revenues: $6,000,000.00Proceeds from sales of investment securities → investing reconciliation: $3,376,000,000.00Proceeds from maturities of investment securities → investing reconciliation: $2,982,000,000.00Proceeds from sale of property and equipment → investing reconciliation: $7,000,000.00investing reconciliation → Purchases of investment securities: $8,185,000,000.00investing reconciliation → Purchases of property and equipment: $575,000,000.00investing reconciliation → Changes in securities lending collateral receivable: $418,000,000.00investing reconciliation → Acquisitions, net of cash and cash equivalents acquired: $89,000,000.00investing reconciliation → Other: $50,000,000.00Net cash used in financing activities → financing reconciliation: $2,487,000,000.00Proceeds from issuance of senior notes, net → financing reconciliation: $2,232,000,000.00Changes in securities lending payable → financing reconciliation: $418,000,000.00Changes in rebate factor payable → financing reconciliation: $123,000,000.00Change in book overdraft → financing reconciliation: $50,000,000.00financing reconciliation → (Payments) receipts from contract deposits, net: $1,933,000,000.00financing reconciliation → Repayment of senior notes: $1,107,000,000.00financing reconciliation → (Repayments) proceeds from issuance of commercial paper, net: $907,000,000.00financing reconciliation → Common stock repurchases: $817,000,000.00financing reconciliation → Dividends paid: $431,000,000.00financing reconciliation → Other, net: $108,000,000.00financing reconciliation → Debt issue costs: $7,000,000.00Net cash used in investing activities → investing reconciliation: $2,952,000,000.00Beginning cash: Cash, cash equivalents, and restricted cash → Cash sources and uses: $4,694,000,000.00Net cash from operating activities → Cash sources and uses: $2,966,000,000.00Cash sources and uses → Ending cash: Cash, cash equivalents, and restricted cash: $2,221,000,000.00Cash sources and uses → Net cash used in investing activities: $2,952,000,000.00Cash sources and uses → Net cash used in financing activities: $2,487,000,000.00Other, net: $108,000,000.00Other operating, net+$108.00 MEquity in net losses: $94,000,000.00Equity-method results+$94.00 MDeferred income taxes: -$192,000,000.00Deferred taxes & credits−$192.00 M(Gain) loss on investment securities, net: -$24,000,000.00Securities gain & loss, net−$24.00 MBenefits payable: $199,000,000.00Health insurance liabilities+$199.00 MReceivables: -$669,000,000.00Receivables, net−$669.00 MStock-based compensation: $207,000,000.00Stock-based compensation+$207.00 MImpairment of property and equipment: $237,000,000.00PP&E impairments+$237.00 MOther liabilities: -$373,000,000.00Other operating liabilities−$373.00 MDepreciation: $908,000,000.00Depreciation expense+$908.00 MImpairment of indefinite-lived intangible assets: $200,000,000.00Indefinite intangible impairment+$200.00 MAmortization: $60,000,000.00Amortization expense+$60.00 MGain on sale of Gentiva Hospice: $0.00Net income: $1,214,000,000.00Net income+$1.21 BUnearned revenues: -$6,000,000.00Deferred revenue−$6.00 MOther assets: $1,003,000,000.00Other operating assets+$1.00 BNet cash from operating activities: $2,966,000,000.00Operating cash+$2.97 BOperating adjustments reconciliation: $3,016,000,000.00Other, net: -$108,000,000.00Other financing, net−$108.00 M(Repayments) proceeds from issuance of commercial paper, net: -$907,000,000.00Commercial paper, net−$907.00 MCommon stock repurchases: -$817,000,000.00Common stock repurchases−$817.00 MRepayment of short-term borrowings: $0.00Repayment of senior notes: -$1,107,000,000.00Senior debt repaid−$1.11 BProceeds from issuance of senior notes, net: $2,232,000,000.00Senior debt issued+$2.23 BDebt issue costs: -$7,000,000.00Debt issuance costs−$7.00 MProceeds from short-term borrowings: $0.00Changes in rebate factor payable: $123,000,000.00Changes in rebate factor payable+$123.00 MDividends paid: -$431,000,000.00Dividends paid−$431.00 MChange in book overdraft: $50,000,000.00Bank overdrafts, net+$50.00 M(Payments) receipts from contract deposits, net: -$1,933,000,000.00(Payments) receipts from contract deposits, net−$1.93 BChanges in securities lending payable: $418,000,000.00Securities lending, net+$418.00 MRepayment of term loan: $0.00Net cash used in financing activities: -$2,487,000,000.00. Cash required to fund net payments.Financing cash−$2.49 Bfinancing reconciliation: $5,310,000,000.00Proceeds from maturities of investment securities: $2,982,000,000.00AFS securities maturities+$2.98 BProceeds from sales of investment securities: $3,376,000,000.00AFS securities sales+$3.38 BPurchases of property and equipment: -$575,000,000.00PP&E purchases−$575.00 MProceeds from sale of property and equipment: $7,000,000.00PP&E sales+$7.00 MPurchases of investment securities: -$8,185,000,000.00AFS securities purchases−$8.19 BOther: -$50,000,000.00Other investing, net−$50.00 MAcquisitions, net of cash and cash equivalents acquired: -$89,000,000.00Acquisitions, net of cash−$89.00 MProceeds from sale of Gentiva Hospice, net: $0.00Changes in securities lending collateral receivable: -$418,000,000.00Securities loan collateral, net−$418.00 MNet cash used in investing activities: -$2,952,000,000.00. Cash required to fund net payments.Investing cash−$2.95 Binvesting reconciliation: $9,317,000,000.00Cash sources and uses: $7,660,000,000.00Beginning cash: Cash, cash equivalents, and restricted cash: $4,694,000,000.00Beginning cash$4.69 BEnding cash: Cash, cash equivalents, and restricted cash: $2,221,000,000.00Ending cash$2.22 BCASH RECONCILIATIONOperatingflowsInvestingflowsFinancingflowsFree cash flow$2.39 BOperating cash − cash spent on PP&ECash flow / Net income2.44×Operating cash flow ÷ net incomeNet cash change−$2.47 BEnding cash − beginning cash
Chart details

HUMANA INC. cash flow reconciliation, Jan 1, 2024 through Dec 31, 2024

Cash flows for Jan 1, 2024 through Dec 31, 2024. Cash basis: Cash, cash equivalents, and restricted cash. Beginning cash: Dec 31, 2023. Ending cash: Dec 31, 2024. Beginning and ending cash are dated balances. Positive cash flows add cash; negative cash flows reduce it.

Beginning cash on Dec 31, 2023
4,694,000,000 US dollars. Beginning cash: Cash, cash equivalents, and restricted cash
Operating activities
2,966,000,000 US dollars. Net cash provided.
Other, net
108,000,000 US dollars
Equity in net losses
94,000,000 US dollars
Deferred income taxes
negative 192,000,000 US dollars
(Gain) loss on investment securities, net
negative 24,000,000 US dollars
Benefits payable
199,000,000 US dollars
Receivables
negative 669,000,000 US dollars
Stock-based compensation
207,000,000 US dollars
Impairment of property and equipment
237,000,000 US dollars
Other liabilities
negative 373,000,000 US dollars
Depreciation
908,000,000 US dollars
Impairment of indefinite-lived intangible assets
200,000,000 US dollars
Amortization
60,000,000 US dollars
Gain on sale of Gentiva Hospice
0 US dollars
Net income
1,214,000,000 US dollars
Unearned revenues
negative 6,000,000 US dollars
Other assets
1,003,000,000 US dollars
Investing activities
negative 2,952,000,000 US dollars. Net cash used.
Proceeds from maturities of investment securities
2,982,000,000 US dollars
Proceeds from sales of investment securities
3,376,000,000 US dollars
Purchases of property and equipment
negative 575,000,000 US dollars
Proceeds from sale of property and equipment
7,000,000 US dollars
Purchases of investment securities
negative 8,185,000,000 US dollars
Other
negative 50,000,000 US dollars
Acquisitions, net of cash and cash equivalents acquired
negative 89,000,000 US dollars
Proceeds from sale of Gentiva Hospice, net
0 US dollars
Changes in securities lending collateral receivable
negative 418,000,000 US dollars
Financing activities
negative 2,487,000,000 US dollars. Net cash used.
Other, net
negative 108,000,000 US dollars
(Repayments) proceeds from issuance of commercial paper, net
negative 907,000,000 US dollars
Common stock repurchases
negative 817,000,000 US dollars
Repayment of short-term borrowings
0 US dollars
Repayment of senior notes
negative 1,107,000,000 US dollars
Proceeds from issuance of senior notes, net
2,232,000,000 US dollars
Debt issue costs
negative 7,000,000 US dollars
Proceeds from short-term borrowings
0 US dollars
Changes in rebate factor payable
123,000,000 US dollars
Dividends paid
negative 431,000,000 US dollars
Change in book overdraft
50,000,000 US dollars
(Payments) receipts from contract deposits, net
negative 1,933,000,000 US dollars
Changes in securities lending payable
418,000,000 US dollars
Repayment of term loan
0 US dollars
Operating adjustment reconciliation
3,016,000,000 US dollars. Intermediate calculation joining the operating reconciliation branches. Its gross amount includes any portion of net income routed through this junction. It is not an additional cash source or use.
financing gross reconciliation
5,310,000,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
investing gross reconciliation
9,317,000,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
Exchange-rate effect
0 US dollars
Ending cash on Dec 31, 2024
2,221,000,000 US dollars. Ending cash: Cash, cash equivalents, and restricted cash
Cash sources and uses
7,660,000,000 US dollars. Opening cash plus net sources, equal to net uses plus ending cash.
Net cash change
negative 2,473,000,000 US dollars. Ending cash minus beginning cash.
Cash flow / Net income
2.44×. Operating cash flow divided by reconciliation net income for the same period. Black from 0.90× through 1.10×; green above 1.10×; red below 0.90×. Color uses the unrounded ratio.
Operating cash flow
2,966,000,000 US dollars. Operating cash flow used in the free cash flow calculation.
Cash purchases of property, plant and equipment
575,000,000 US dollars. These cash purchases are already included in investing activities above.
Free cash flow
2,391,000,000 US dollars. A supplemental measure; finance-lease payments are excluded from this definition.

Chart connections

  • Beginning cash plus operating, investing and financing cash flows plus the exchange-rate effect equals ending cash. Negative amounts reduce cash.
  • Financing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Investing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Operating reconciliation adjustments are not all independent cash receipts.
  • Net income enters operating cash directly in the reconciliation. The adjustment junction contributes the remaining $1.75B after reconciling the other positive and negative adjustments. These connections depict an accounting reconciliation, not traced cash receipts.
  • Each activity has one net cash bar connected to the shared cash pool. Positive activity totals enter the pool; negative activity totals leave the pool to fund that activity's net payments. The central pool does not assign a particular funding source to a particular payment.
  • The intermediate calculation bars include both sides of the displayed activity breakdowns; they are not additional cash flows.
  • Operating cash flow minus cash purchases of property, plant and equipment equals free cash flow: 2,966,000,000 US dollars minus 575,000,000 US dollars equals 2,391,000,000 US dollars.
HUMANA INC. (HUM) FY2024 Annual Statement of Cash Flows Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!